Lillian Weitz
Associate
Lillian Weitz is an associate in Goodwin’s Business Law department. Lillian joined Goodwin in 2025.
representative matters
Lilly’s recent representative matters include:
Represented the underwriters (including Goldman Sachs & Co. LLC, Jefferies, and Evercore ISI as joint bookrunning managers and Wedbush PacGrow as lead manager) on Hemab Therapeutics Holdings, Inc.’s initial public offering for total gross proceeds of approximately $350 million.
Credentials
Education
JD2025
Washington and Lee University School of Law
(cum laude)
BS2022
Washington and Lee University
Admissions
Bars
- New York